Nanocrystalline Megestrol + Immunochemo As 1st-Line for ES-SCLC Cachexia

Clinical trial NCT06793228 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06793228
Sponsor: Henan Cancer Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

SCLC, Extensive Stage

Start date: 2025-01-15
Primary completion: 2027-01-15
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.